BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 20, 2021
View Archived Issues
Sanofi begins phase II study of SAR-443122 in cutaneous lupus erythematosus
Read More
Structural basis for the design of novel suramin derivatives as SARS-CoV-2 RdRp inhibitors
Read More
Enrollment opens in phase II study of RO-7049665 in autoimmune hepatitis
Read More
Dosing begins in phase I/II study of Covigenix VAX-001 for SARS-CoV-2
Read More
FDA clears XBiotech to begin phase I/II study of XB-2001 in pancreatic cancer
Read More
Peptron and Qilu sign licensing agreement for Peptron's PAb001-ADC
Read More
Zenshine PI3Kgamma inhibitor ZX-4081 functions by reprogramming the tumor microenvironment
Read More
FDA clears IND application for ALLO-605 for the treatment of multiple myeloma
Read More
Promising data reported from phase Ib ZUMA-19 study of lenzilumab in DLBCL
Read More
Genentech's GNE-7883 inhibits YAP/TAZ-TEAD interaction
Read More
Interim results show efficacy of gene therapy RP-L201 in pediatric leukocyte adhesion deficiency I
Read More
FDA clears IND to initiate LUMINOS-103 study of PVSRIPO in patients with advanced solid tumors
Read More
BeiGene patents new PROTACs for cancer
Read More
Roche discloses MGL inhibitors
Read More
Betta Pharmaceuticals identifies IDH2 mutant inhibitors
Read More
Suzhou Ark Biopharmaceutical identifies new compounds for HBV infection
Read More
Seoul National University discloses vaccine against SFTS virus
Read More
Tonix enters into worldwide licensing agreement with OyaGen to develop TNX-3500 for COVID-19
Read More
BO-2762: a potential candidate for colorectal cancer
Read More
Researchers give preclinical details on CARG-2020, an artificial oncolytic virus for ovarian cancer
Read More
TP-5809 shows potent inhibition of tumor growth in a model of Hodgkin's lymphoma
Read More
New phase III trial evaluates tafasitamab with lenalidomide and rituximab in FL and MZL
Read More
ZX-101A inhibits tumor growth by enhancing antitumor immunity
Read More
New technique casts light on stem cell differentiation
Read More
InterveXion reports phase II data on IXT-m200 in methamphetamine use disorder
Read More
European Commission approves Epidyolex for tuberous sclerosis complex
Read More